Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Latanoprost in Open-Angle Glaucoma or Ocular Hypertension
NCT00051142Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2001
- Primary completion
- Jun 2004
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoints: Mean Intraocular Pressure at Month 12 and Mean Change in Intraocular Pressure from Baseline at Month 12. Started Feb 2001; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00051142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051142.